Conquering Epidemics

We can never stop fighting

Humans and pathogens are locked in a bitter arms race—and the pathogens are winning. They are evolving to resist our best medicines, and humanity’s pipeline of effective antibiotic weapons is empty. Meanwhile, in a world of packed cities, constant travel, and a warming planet, the danger of a massive outbreak is more acute than ever.

We’re fighting on many fronts to make sure humanity is ready when the next big outbreak happens. Whether it’s a virulent new virus or a persistent killer like AIDS, TB, or Malaria, we’re determined to outsmart our infectious disease foes. We’re mining mountains of data to reveal clues about how these diseases spread. We’re cracking the pathogens’ biological codes. And we’re helping teams around the world build better systems for surveillance and response.

We’re stopping patient 0 from leading to patient 6.7 billion.

Center for Communicable Disease Dynamics
The Center for Communicable Disease Dynamics (CCDD) has been a key center for research and policy analysis on the SARS-CoV-2 virus, and has been at the forefront of the COVID-19 response.
Learn More

Recent Stories

Victor De Gruttola’s storied career celebrated at biostatistics symposium

Members of the Department of Biostatistics recently gathered for a symposium celebrating the 50-year career of Victor De Gruttola, former chair and professor of biostatistics emeritus.

Op-ed: New standards could greatly improve indoor air

New indoor ventilation targets from the Centers for Disease Control and Prevention, as well as enhanced ventilation standards from an industry group, could help significantly reduce the spread of infectious diseases, according to Harvard Chan School’s Joseph Allen.

‘Emergency’ may be over but COVID still a threat, experts say

In the wake of the World Health Organization’s declaration on May 5 that it was ending the COVID global health emergency, experts acknowledged that the disease now poses much less of threat than it has over the past…

PEPFAR program marks 20 years, 20 million lives saved

PEPFAR was the largest public health effort by one country against a single disease, and as of late last year, has provided lifesaving treatment to more than 20 million people suffering from HIV/AIDS.

Alberto Ascherio, Marc Lipsitch among STAT’s picks for top leaders in life sciences

Harvard Chan School’s Alberto Ascherio and Marc Lipsitch are among 46 individuals in life sciences named to the 2023 STATUS List—a group of leaders in public health, medicine, biotechnology, and more, recognized by STAT for their contributions to…

Caroline Buckee
Associate Professor of Epidemiology

"One of the key things you want to know about an infectious disease is where is it spreading, how quickly, to which populations? Traditionally, we’ve had very few sources of data about how people move around. But today, everyone has a mobile phone."
Read More About the Frontiers
Yonatan Grad
Melvin J. and Geraldine L. Glimcher Assistant Professor of Immunology and Infectious Diseases

"In the future, our understanding of the diversity of pathogen species, and the interaction between host and pathogen, will improve."
Read More About the Frontiers
Jessica Cohen
Bruce A. Beal, Robert L. Beal, and Alexander S. Beal Associate Professor of Global Health

"Over the next 30 to 50 years, a game changer would be a highly effective malaria vaccine... Meanwhile, lots of kids with malaria are misdiagnosed or undertreated. A vaccine would allow us to circumvent these many behavioral barriers."
Read More About the Frontiers
Jeff Wagner
Postdoctoral Fellow in the Department of Immunology and Infectious Diseases

"In the near future, we’re going to see rapid diagnostic tests: for example, a simple and cheap readout that says whether a person has Zika or dengue—two viruses with similar symptoms."
Read More About the Frontiers